Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
IJRM-Iranian Journal of Reproductive Medicine. 2012; 10 (4): 363-372
em Inglês | IMEMR | ID: emr-132389

RESUMO

Osteoporosis is a chronic disease characterized by a decrease in bone mineral density [BMD] and corruption of the microarchitectural structure of bone tissue. It was investigated whether methylprednisolone had a favorable effect on osteoporotic bone tissue in Oophorectomy induced osteoporotic rats whose endogenous adrenaline levels are suppressed with metyrosine. Bone Mineral Density, number of osteoblast-osteoclast, bone osteocalcin levels and alkaline phosphatase [ALP] measurements were performed. Obtained results were compared with that of alendronate. Oophorectomy induced osteoporosis was exacerbated by methylprednisolone. Alentronate prevented ovariectomised induced osteoporosis, but it couldn't prevent methylprednisolone +ovariectomised induced osteoporosis in rats. Combined treatment with methylprednisolon and metyrosine was the best treatment for preventing osteoporosis but metyrosine alone couldn't prevent osteoporosis in ovariectomised rats


Assuntos
Feminino , Animais de Laboratório , Metiltirosinas , Ratos , Osteoclastos/efeitos dos fármacos , Prednisolona , Prednisolona/efeitos adversos , Combinação de Medicamentos , Ovariectomia/efeitos adversos , Osteoblastos/efeitos dos fármacos , Densidade Óssea/efeitos dos fármacos , Metilprednisolona/efeitos adversos , Metilprednisolona , Osteocalcina/efeitos dos fármacos , Fosfatase Alcalina , Alendronato , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA